Changes in Plasma Lipids and Lipoproteins during Isotretinoin Therapy for Acne
- 17 October 1985
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 313 (16), 981-985
- https://doi.org/10.1056/nejm198510173131604
Abstract
Abnormalities in plasma lipids are a recognized side effect of isotretinoin therapy for nodulocystic acne. We studied 60 patients during 20 weeks of isotretinoin therapy, to measure changes in plasma lipids and lipoproteins, to compare plasma lipid responses in men and women, and to determine whether there are alterations in levels of lipoprotein lipase or hepatic triglyceride lipase that could explain the development of isotretinoin-induced hypertriglyceridemia.This publication has 31 references indexed in Scilit:
- Treatment of common lipoprotein disordersProgress in Cardiovascular Diseases, 1984
- Isotretinoin therapy for acne: Results of a multicenter dose-response studyJournal of the American Academy of Dermatology, 1984
- Isotretinoin treatment of acne and related disorders: An updateJournal of the American Academy of Dermatology, 1983
- Etretinate A Review of its Pharmacological Properties and Therapeutic Efficacy in Psoriasis and Other Skin DisordersDrugs, 1983
- A dose-response study of 13-cis-retinoic acid in acne vulgarisBritish Journal of Dermatology, 1983
- Changes in lipid metabolism during retinoid administrationJournal of the American Academy of Dermatology, 1982
- General clinical toxicology of oral retinoidsJournal of the American Academy of Dermatology, 1982
- Pharmacokinetics of the retinoids isotretinoin and etretinateJournal of the American Academy of Dermatology, 1982
- Isotretinoin versus placebo in the treatment of cystic acneJournal of the American Academy of Dermatology, 1982
- Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic AcidNew England Journal of Medicine, 1979